🇺🇸 FDA
Pipeline program

DCVax-L and T Cells

UPCC 01808

Phase 2 mab terminated

Quick answer

DCVax-L and T Cells for Ovarian Cancer is a Phase 2 program (mab) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NORTHWEST BIOTHERAPEUTICS INC
Indication
Ovarian Cancer
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials